Selection of high-imagery words for the study of episodic memory from middle childhood to old age

The goal of the present study was to select a set of highly imaginable and concrete words that can be used in age-comparable memory research. The selection process included two steps. First, 10 children aged 7-9 years rated 400 high-imagery, concrete, and meaningful words selected from an existing corpus of 1082 spoken words (Singer et al., 2003) on a three-point scale of comprehensibility. Second, two independent raters further selected words to reduce the likelihood of lexical error during recall. As a result, 413 words were retained as stimulus materials for age-comparative investigations of episodic memory performance

Magnetic small-angle neutron scattering

Small-angle neutron scattering (SANS) is one of the most important techniques for microstructure determination, being utilized in a wide range of scientific disciplines, such as materials science, physics, chemistry, and biology. The reason for its great significance is that conventional SANS is probably the only method capable of probing structural inhomogeneities in the bulk of materials on a mesoscopic real-space length scale from roughly 1 to 300 nm. Moreover, the exploitation of the spin degree of freedom of the neutron provides SANS with a unique sensitivity to study magnetism and magnetic materials at the nanoscale. As such, magnetic SANS ideally complements more real-space and surface-sensitive magnetic imaging techniques, e.g., Lorentz transmission electron microscopy, electron holography, magnetic force microscopy, Kerr microscopy, or spin-polarized scanning tunneling microscopy. This review summarizes the recent applications of the SANS method to study magnetism and magnetic materials. This includes a wide range of materials classes from nanomagnetic systems such as soft magnetic Fe-based nanocomposites, hard magnetic Nd-Fe-B-based permanent magnets, magnetic steels, ferrofluids, nanoparticles, and magnetic oxides to more fundamental open issues in contemporary condensed matter physics such as skyrmion crystals, noncollinear magnetic structures in noncentrosymmetric compounds, magnetic or electronic phase separation, and vortex lattices in type-II superconductors. Special attention is paid not only to the vast variety of magnetic materials and problems where SANS has provided direct insight, but also to the enormous progress made regarding the micromagnetic simulation of magnetic neutron scattering

AMPHIBIAN GNRL simulated data SANS review_RevModPhys2019 [Dataset]

UE, programa H2020, Proyecto AMPHIBIAN n º 720853Peer reviewe

The High-Resolution Coronal Imager (Hi-C)

The High-Resolution Coronal Imager (Hi-C) was flown on a NASA sounding rocket on 11 July 2012. The goal of the Hi-C mission was to obtain high-resolution (≈ 0.3 - 0.4′′), high-cadence (≈ 5 seconds) images of a solar active region to investigate the dynamics of solar coronal structures at small spatial scales. The instrument consists of a normal-incidence telescope with the optics coated with multilayers to reflect a narrow wavelength range around 19.3 nm (including the Fe xii 19.5-nm spectral line) and a 4096×4096 camera with a plate scale of 0.1′′ pixel-1. The target of the Hi-C rocket flight was Active Region 11520. Hi-C obtained 37 full-frame images and 86 partial-frame images during the rocket flight. Analysis of the Hi-C data indicates the corona is structured on scales smaller than currently resolved by existing satellite missions. © 2014 Springer Science+Business Media Dordrecht (outside the USA)

Mutations in Three Genes Encoding Proteins Involved in Hair Shaft Formation Cause Uncombable Hair Syndrome

International audienceUncombable hair syndrome (UHS), also known as “spun glass hair syndrome,” “pili trianguli et canaliculi,” or “cheveux incoiffables” is a rare anomaly of the hair shaft that occurs in children and improves with age. UHS is characterized by dry, frizzy, spangly, and often fair hair that is resistant to being combed flat. Until now, both simplex and familial UHS-affected case subjects with autosomal-dominant as well as -recessive inheritance have been reported. However, none of these case subjects were linked to a molecular genetic cause. Here, we report the identification of UHS-causative mutations located in the three genes PADI3 (peptidylarginine deiminase 3), TGM3 (transglutaminase 3), and TCHH (trichohyalin) in a total of 11 children. All of these individuals carry homozygous or compound heterozygous mutations in one of these three genes, indicating an autosomal-recessive inheritance pattern in the majority of UHS case subjects. The two enzymes PADI3 and TGM3, responsible for posttranslational protein modifications, and their target structural protein TCHH are all involved in hair shaft formation. Elucidation of the molecular outcomes of the disease-causing mutations by cell culture experiments and tridimensional protein models demonstrated clear differences in the structural organization and activity of mutant and wild-type proteins. Scanning electron microscopy observations revealed morphological alterations in hair coat of Padi3 knockout mice. All together, these findings elucidate the molecular genetic causes of UHS and shed light on its pathophysiology and hair physiology in general

Empagliflozin in Patients with Chronic Kidney Disease

Background The effects of empagliflozin in patients with chronic kidney disease who are at risk for disease progression are not well understood. The EMPA-KIDNEY trial was designed to assess the effects of treatment with empagliflozin in a broad range of such patients. Methods We enrolled patients with chronic kidney disease who had an estimated glomerular filtration rate (eGFR) of at least 20 but less than 45 ml per minute per 1.73 m(2) of body-surface area, or who had an eGFR of at least 45 but less than 90 ml per minute per 1.73 m(2) with a urinary albumin-to-creatinine ratio (with albumin measured in milligrams and creatinine measured in grams) of at least 200. Patients were randomly assigned to receive empagliflozin (10 mg once daily) or matching placebo. The primary outcome was a composite of progression of kidney disease (defined as end-stage kidney disease, a sustained decrease in eGFR to < 10 ml per minute per 1.73 m(2), a sustained decrease in eGFR of & GE;40% from baseline, or death from renal causes) or death from cardiovascular causes. Results A total of 6609 patients underwent randomization. During a median of 2.0 years of follow-up, progression of kidney disease or death from cardiovascular causes occurred in 432 of 3304 patients (13.1%) in the empagliflozin group and in 558 of 3305 patients (16.9%) in the placebo group (hazard ratio, 0.72; 95% confidence interval [CI], 0.64 to 0.82; P < 0.001). Results were consistent among patients with or without diabetes and across subgroups defined according to eGFR ranges. The rate of hospitalization from any cause was lower in the empagliflozin group than in the placebo group (hazard ratio, 0.86; 95% CI, 0.78 to 0.95; P=0.003), but there were no significant between-group differences with respect to the composite outcome of hospitalization for heart failure or death from cardiovascular causes (which occurred in 4.0% in the empagliflozin group and 4.6% in the placebo group) or death from any cause (in 4.5% and 5.1%, respectively). The rates of serious adverse events were similar in the two groups. Conclusions Among a wide range of patients with chronic kidney disease who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease or death from cardiovascular causes than placebo